BiomX Inc.

Historical 13F Holders

Symbol
PHGE
CUSIP
09090D301
All holders as of
Q3 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 09090D301 since 12/18/2024, newest first.

Filer % of Class Filed
Alyeska Investment Group, L.P. 13G/A Amendment 1
2.5% 2/17/2026
Event 12/31/2025
Orin Hirschman 13G/A Amendment 1
0.1% 1/29/2026
Event 12/31/2025
Reuven Yeganeh 13D
20.0% 1/26/2026
Event 12/26/2025
Morgan Stanley 13G/A Amendment 1
0% 8/7/2025
Event 7/31/2025
Morgan Stanley 13G
7.1% 8/5/2025
Event 6/30/2025
Centaurus Investments Ltd 13G
7.6% 5/15/2025
Event 4/21/2025
Alyeska Investment Group, L.P. 13G
9.3% 5/15/2025
Event 3/31/2025
Nantahala Capital Management, LLC 13G/A Amendment 1
10.0% 5/15/2025
Event 3/31/2025
Orin Hirschman 13G
6.3% 5/8/2025
Event 3/31/2025
Nantahala Capital Management, LLC 13G
10.0% 11/13/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 18 8.74 M $4.59 M
2025 Q2 18 10.8 M $4.88 M
2025 Q1 20 13.3 M $7.39 M
2024 Q4 18 9.96 M $7.25 M
2024 Q3 14 8.75 M $8.93 M